IgG4‐related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study
Journal of Hepato-Biliary-Pancreatic Sciences · 2024
DOI: 10.1002/jhbp.1404 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Yusuke Kurita und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Yokohama City University Hospital, Yokohama, Japan. Hauptthemen laut MEDLINE: Pancreatitis, Autoimmune Pancreatitis, Autoimmune Diseases, Cholangitis, Sclerosing. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
The risk and prognosis of pancreatobiliary cancer and in patients with autoimmune pancreatitis (AIP) and IgG4‐related sclerosing cholangitis (IgG4‐SC) remain unclear. Therefore, we retrospectively investigated the risk of pancreatobiliary cancer and prognosis in patients with AIP and IgG4‐SC.
Methods
Patients with AIP and IgG4‐SC at seven centers between 1998 and 2022 were investigated. The following data were evaluated: (1) the number of cancers diagnosed and standardized incidence ratio (SIR) for pancreatobiliary and other cancers during the observational period and (2) prognosis after diagnosis of AIP and IgG4‐SC using standardized mortality ratio (SMR).
Results
This study included 201 patients with AIP and IgG4‐SC. The mean follow‐up period was 5.7 years. Seven cases of pancreatic cancer were diagnosed, and the SIR was 8.11 (95% confidence interval [CI]: 7.29–9.13). Three cases of bile duct cancer were diagnosed, and the SIR was 6.89 (95% CI: 6.20–7.75). The SMR after the diagnosis of AIP and IgG4‐SC in cases that developed pancreatobiliary cancer were 4.03 (95% CI: 2.83–6.99).
Conclusions
Patients with autoimmune pancreatitis and IgG4‐SC were associated with a high risk of pancreatic and bile duct cancer. Patients with AIP and IgG4‐SC have a worse prognosis when they develop pancreatobiliary cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Yokohama City University Hospital, Yokohama, Japan.
- Department of Hepato-Biliary-Pancreatic Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
- Department of Gastroenterology, Yokohama Rosai Hospital, Yokohama, Japan.
- Department of Gastroenterology, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.
- Department of Gastroenterology, Hiratsuka City Hospital, Hiratsuka, Japan.
- Department of Gastroenterology, Keiyu Hospital, Yokohama, Japan.
ORCID-Profile: Yusuke Kurita, Kensuke Kubota, Shin Yagi, Sho Hasegawa, Kunihiro Hosono, Noritoshi Kobayashi, Itaru Endo
Zitieren
APA
Kurita, Y., Kubota, K., Fujita, Y., Tsujino, S., Sekino, Y., Kasuga, N., Iwasaki, A., Iwase, M., Izuka, T., Kagawa, K., Tanida, E., Yagi, S., Hasegawa, S., Sato, T., Hosono, K., Kobayashi, N., Ichikawa, Y., Nakajima, A., & Endo, I. (2024). IgG4‐related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1404
Vancouver
Kurita Y, Kubota K, Fujita Y, Tsujino S, Sekino Y, Kasuga N, et al. IgG4‐related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1404
BibTeX
@article{Kurita2024,
author = {Kurita, Yusuke and Kubota, Kensuke and Fujita, Yuji and Tsujino, Seitaro and Sekino, Yusuke and Kasuga, Noriki and Iwasaki, Akito and Iwase, Mai and Izuka, Takeshi and Kagawa, Koichi and Tanida, Emiko and Yagi, Shin and Hasegawa, Sho and Sato, Takamitsu and Hosono, Kunihiro and Kobayashi, Noritoshi and Ichikawa, Yasushi and Nakajima, Atsushi and Endo, Itaru},
title = {IgG4‐related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
doi = {10.1002/jhbp.1404}
}
EUVIMED